• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Scinai Immunotherapeutics Ltd. - American Depositary Shares (NQ: SCNI )

    3.440 +0.090 (+2.69%)
    Streaming Delayed Price Updated: 3:15 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,534
    Open 3.300
    Bid (Size) 3.320 (1)
    Ask (Size) 3.440 (1)
    Prev. Close 3.350
    Today's Range 3.300 - 3.540
    52wk Range 2.230 - 8.920
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary
    Via Investor Brand Network
    Cases of Parvovirus B19 Spike in the US
    Via Investor Brand Network

    Performance

    YTD
    -43.58%
    -43.58%
    1 Month
    -2.55%
    -2.55%
    3 Month
    -0.86%
    -0.86%
    6 Month
    +7.50%
    +7.50%
    1 Year
    -45.48%
    -45.48%

    More News

    Read More
    BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Strategic Board Appointment
    Via Investor Brand Network
    BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board
    Via Investor Brand Network
    New Drug Approach Could Roll Back Pancreatic Cancer Immunotherapy Resistance
    Via Investor Brand Network
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Nine-Month Financial Results and Business Update
    Via Investor Brand Network
    New Toolkit Launched to Boost Marburg Screening Readiness in the US
    Via Investor Brand Network
    BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Spotlight Innovative I&I Pipeline and CDMO Services at BIO-Europe 2024
    Via Investor Brand Network
    Researchers Shine Spotlight on New Barriers to Vaccination
    Via Investor Brand Network
    Exposures COVID-19
    Whooping Cough Prevalence Rises in US as Missed Shots During Pandemic Come Home to Roost
    Via Investor Brand Network
    BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque Psoriasis, Its Promising Novel Solution
    Via Investor Brand Network
    BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Featured Guest on Latest Episode of BioMedWire Podcast
    Via Investor Brand Network
    New Approach Could Boost Effectiveness of Immunotherapies Against Colorectal Cancer
    Via Investor Brand Network
    BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement
    Via Investor Brand Network
    BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder
    Via Investor Brand Network
    SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q2 2024
    Via InvestorPlace
    BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update
    Via Investor Brand Network
    BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Signs Definitive Loan Restructuring Agreement with EIB Converting Debt into Equity
    Via Investor Brand Network
    Australia Launches Novel Immunotherapy Program to Help Babies with Peanut Allergies
    Via Investor Brand Network
    7 F-Rated Stocks for Your August 2024 Sell List
    Via InvestorPlace
    Study Highlights Heightened Risk of Diseases Spreading from Animals to Humans
    Via Investor Brand Network
    BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives PEI Feedback Regarding Development, Preclinical Trial of Anti-IL-17 NanoAb
    Via Investor Brand Network
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.